Viewing nowRostastatin 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
R.P. Bio Co., Ltd.

MFDS item code 201603489 · Approved 2016.06.15 · Insurance code 661604760
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone do not control the condition. It is also beneficial in patients with homozygous familial hypercholesterolemia when used alongside diet or other lipid-lowering treatments. This drug reduces total cholesterol and LDL-cholesterol levels, effectively slowing the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients aged 10 to 17 years who meet specific criteria for heterozygous familial hypercholesterolemia. In patients with primary dysbetalipoproteinemia, it also acts as an adjunct to diet and contributes to reducing the risks of stroke, myocardial infarction, and arterial revascularization in adult patients at high risk for cardiovascular disease. Overall, this drug is used to effectively improve cholesterol levels and lower the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be administered at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Aged 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Younger than 10 years: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, patients who are allergic to this drug, those with severely impaired liver function, patients with muscular diseases, those with severe renal impairment, women who are pregnant or breastfeeding, and women of childbearing age who do not use appropriate contraception should not take this drug. Additionally, caution is especially warranted in patients at high risk of muscle ailments, and high-dose administration is contraindicated. This drug contains lactose; thus, patients with lactose intolerance should not take it. Before taking this drug, regular liver function tests and muscle-related tests should be conducted, and patients with a history of liver disease or excessive alcohol consumption should be particularly cautious. If symptoms such as muscle pain, muscle weakness, or cramps occur, immediate notification to a healthcare provider is necessary, and in severe cases, discontinuation of treatment should happen. This drug can rarely cause serious skin reactions or liver damage; therefore, if symptoms such as skin rash, jaundice, or severe fatigue appear, it is essential to stop taking the medication immediately and consult with healthcare personnel. Moreover, this drug may interact with other medications, so if other medications are being taken, patients must inform their doctor or pharmacist. Caution is required when co-administered with specific medications, as this may increase the concentration of this drug and elevate the risk of muscle side effects. Women who are pregnant or planning to become pregnant should not take this drug, and if pregnancy is confirmed during treatment, discontinuation should occur immediately. Breastfeeding women are also advised to avoid this medication. In the event of an overdose, there is no specific antidote, and treatment should be symptomatic, with monitoring of liver function and muscle enzyme levels. Caution is necessary while driving or operating machinery due to potential dizziness.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, fatigue, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to protect it from air or moisture and is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medicine's effectiveness.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
R.P. Bio Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.